No connection

Search Results

SY

BEARISH
$2.9 Live
So-Young International Inc. · NASDAQ
Target $7.71 (+165.8%)
$0.74 52W Range $6.28

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 21, 2026
Market cap
$290.63M
P/E
N/A
ROE
-13.6%
Profit margin
-15.9%
Debt/Equity
0.18
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
80%
SY presents a contradictory profile: a stable Piotroski F-Score of 5/9 and strong liquidity, contrasted by a catastrophic earnings track record. While the company maintains a very low Price-to-Sales ratio (0.19) and healthy revenue growth (24.8% YoY), it has failed to beat earnings estimates in the last four quarters with massive negative surprises. The technical trend is completely bearish (0/100), and the shift from profitability in 2024 back to significant losses in 2025-2026 suggests a failing operational turnaround.

Key Strengths

Very low Debt/Equity ratio (0.18)
Strong top-line revenue growth (24.8% YoY)
Healthy liquidity with a Current Ratio of 1.89
Strong Gross Margin of 47.77%
Extremely low valuation on a Price-to-Sales basis (0.19)

Key Risks

Severe earnings volatility and consistent misses (0/4 last 4 quarters)
Negative profit margins (-15.90%) and operating margins (-22.41%)
Bearish technical trend (0/100)
Negative Forward P/E indicating continued losses
Weak insider sentiment (40/100)
AI Fair Value Estimate
Based on comprehensive analysis
$3.2
+10.3% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
33
Weak
Value
50
Future
30
Past
20
Health
65
Dividend
0
AI Verdict
Speculative/High Risk
Key drivers: Catastrophic earnings surprises, Strong revenue growth vs negative profitability, Low debt levels
Confidence
85%
Value
50/100

Trades at a deep discount to sales, but value is eroded by lack of profitability.

Positives
  • P/S of 0.19 is deeply undervalued
  • P/B of 1.28 is reasonable
Watchpoints
  • Negative Forward P/E
  • No Graham Number available due to lack of earnings
Future
30/100

Revenue growth is not translating into bottom-line results.

Positives
  • YoY Revenue growth of 24.8%
Watchpoints
  • Earnings trajectory is sharply declining
  • Negative operating margins
Past
20/100

Historical performance is characterized by extreme volatility and long-term value destruction.

Positives
  • 1Y price recovery of 262.5%
Watchpoints
  • 5Y change of -65.4%
  • Extreme negative earnings surprises in 2025
Health
65/100

Balance sheet is the strongest part of the company, providing a buffer against insolvency.

Positives
  • Piotroski F-Score of 5/9 (Stable)
  • Low Debt/Equity (0.18)
  • Current Ratio 1.89
Watchpoints
  • Negative ROE and ROA
Dividend
0/100

Not a dividend-paying stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.9
Analyst Target
$7.71
Upside/Downside
+165.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SY and closest competitors.

Updated 2026-04-20
SY
So-Young International Inc.
Primary
5Y
-65.4%
3Y
+13.5%
1Y
+262.5%
6M
-7.9%
1M
0.0%
1W
+7.8%
SLP
Simulations Plus, Inc.
Peer
5Y
-76.6%
3Y
-65.8%
1Y
-56.0%
6M
-6.7%
1M
+23.6%
1W
+10.2%
ANL
Adlai Nortye Ltd.
Peer
5Y
-47.0%
3Y
-47.0%
1Y
+247.2%
6M
+345.4%
1M
-14.4%
1W
-10.8%
SEN
Senseonics Holdings, Inc.
Peer
5Y
-81.7%
3Y
-46.7%
1Y
-43.6%
6M
-17.0%
1M
+6.8%
1W
+1.4%
TLS
TriSalus Life Sciences, Inc.
Peer
5Y
-53.2%
3Y
-55.4%
1Y
-18.3%
6M
-12.9%
1M
+17.1%
1W
+5.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-24.96
PEG Ratio
N/A
P/B Ratio
1.28
P/S Ratio
0.19
EV/Revenue
-0.15
EV/EBITDA
1.06
Market Cap
$290.63M

Profitability

Profit margins and return metrics

Profit Margin -15.9%
Operating Margin -22.41%
Gross Margin 47.77%
ROE -13.61%
ROA -6.19%

Growth

Revenue and earnings growth rates

Revenue Growth +24.8%
Earnings Growth N/A
Q/Q Revenue Growth +3.99%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.18
Low debt
Current Ratio
1.89
Good
Quick Ratio
1.2
Good
Cash/Share
$11.31

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-15
$N/A
2026-03-25
$-0.93
-35.9% surprise
2025-11-17
$-1.03
-6900.1% surprise
2025-08-15
$-0.3
-66.6% surprise

Healthcare Sector Comparison

Comparing SY against 495 companies in the Healthcare sector (27 bullish, 152 neutral, 316 bearish)
Return on Equity (ROE)
-13.61%
This Stock
vs
-95.69%
Sector Avg
-85.8% (Below Avg)
Profit Margin
-15.9%
This Stock
vs
-15.8%
Sector Avg
+0.7% (Better)
Debt to Equity
0.18
This Stock
vs
2.89
Sector Avg
-93.8% (Less Debt)
Revenue Growth
24.8%
This Stock
vs
138.42%
Sector Avg
-82.1% (Slower)
Current Ratio
1.89
This Stock
vs
4.66
Sector Avg
-59.4% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2025-04-18

SY filed its annual report on Form 20-F on April 18, 2025. Due to the absence of provided excerpts, specific financial highlights and risk factors are unavailable for summary.

20-F
FORM 20-F
2024-04-25

SY filed its Form 20-F annual report on April 25, 2024. Specific financial highlights and risk factors were not provided in the available metadata for analysis.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning SY from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile